Literature DB >> 25489271

Response to "Need to minimize bias when surveying patient attitudes to stopping cml treatment".

David Sanford1, Rachel Kyle2, Alejandro Lazo-Langner3, Anargyros Xenocostas4, Ian Chin-Yee4, Kang Howson-Jan4, Cyrus C Hsia5.   

Abstract

Entities:  

Year:  2014        PMID: 25489271      PMCID: PMC4257128          DOI: 10.3747/co.21.2200

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  6 in total

Review 1.  Shared decision making in oncology practice: what do oncologists need to know?

Authors:  Mary C Politi; Jamie L Studts; John W Hayslip
Journal:  Oncologist       Date:  2012-01-10

Review 2.  Preferences for cancer treatments: an overview of methods and applications in oncology.

Authors:  P Blinman; M King; R Norman; R Viney; M R Stockler
Journal:  Ann Oncol       Date:  2012-01-10       Impact factor: 32.976

3.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Authors:  C S Cleeland; T R Mendoza; X S Wang; C Chou; M T Harle; M Morrissey; M C Engstrom
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

4.  Lack of congruence between patients' and health professionals' perspectives of adherence to imatinib therapy in treatment of chronic myeloid leukemia: A qualitative study.

Authors:  Simon Wu; Desmond Chee; Anna Ugalde; Phyllis Butow; John Seymour; Penelope Schofield
Journal:  Palliat Support Care       Date:  2014-02-13

5.  Concurrent and predictive validity of a self-reported measure of medication adherence.

Authors:  D E Morisky; L W Green; D M Levine
Journal:  Med Care       Date:  1986-01       Impact factor: 2.983

6.  Characteristics of physicians with participatory decision-making styles.

Authors:  S H Kaplan; S Greenfield; B Gandek; W H Rogers; J E Ware
Journal:  Ann Intern Med       Date:  1996-03-01       Impact factor: 25.391

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.